Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2014 Jul 20;146(3):543–555. doi: 10.1007/s10549-014-3059-7

Fig. 3.

Fig. 3

ZER treatment increased HES-1A/B-associated luciferase activity in breast cancer cells. HES-1A/B luciferase activity in MDA-MB-231, MCF-7, and SUM159 cells after 12 or 24 h treatment with ZER relative to corresponding DMSO-treated control. Results shown are mean ± SD (n=3). *Significantly different (P<0.05) compared with DMSO control by one-way ANOVA followed by Dunnett’s test. Results were comparable in replicate independent experiments.